Cargando…
The Role of Connexin 43 in Renal Disease: Insights from In Vivo Models of Experimental Nephropathy
Renal disease is a major public health challenge since its prevalence has continuously increased over the last decades. At the end stage, extrarenal replacement therapy and transplantation remain the only treatments currently available. To understand how the disease progresses, further knowledge of...
Autores principales: | Roger, Elena, Boutin, Louis, Chadjichristos, Christos E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656944/ https://www.ncbi.nlm.nih.gov/pubmed/36361888 http://dx.doi.org/10.3390/ijms232113090 |
Ejemplares similares
-
Connexin 43: A Target for the Treatment of Inflammation in Secondary Complications of the Kidney and Eye in Diabetes
por: Cliff, Chelsy L., et al.
Publicado: (2022) -
Blocking Connexin-43 mediated hemichannel activity protects against early tubular injury in experimental chronic kidney disease
por: Price, Gareth W., et al.
Publicado: (2020) -
Connexin-43 hemichannels orchestrate NOD-like receptor protein-3 (NLRP3) inflammasome activation and sterile inflammation in tubular injury
por: Roger, Elena, et al.
Publicado: (2023) -
Connexin 43-autophagy loop in the podocyte injury of diabetic nephropathy
por: Ji, Jialing, et al.
Publicado: (2019) -
Connexin43 Hemichannel-Mediated Regulation of Connexin43
por: Li, Kai, et al.
Publicado: (2013)